ChemoMetec A/S

Research ChemoMetec A/S (CHEMM) on Bullrun: market cap DKK 6.45B, P/E 36.4, dividend yield 1.9%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCHEMM
• ExchangeCO
• CountryDenmark
• SectorHealthcare
• IndustryMedical Devices
• CurrencyDKK
• Market capDKK 6.45B
• P/E36.4
• Dividend yield1.9%
• Financial periodFY2025
• RevenueDKK 495.57M
• Revenue growth21.5%
• Net incomeDKK 186.41M
• Free cash flowDKK 142.71M
• Gross margin93.9%

Valuation Snapshot

latest market cap is DKK 6.45B; P/E is 36.4; dividend yield is 1.9%.

About ChemoMetec A/S

ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in the areas of cell and gene therapy, cancer and stem cell research, and development and manufacturing of pharmaceuticals, as well as production and quality control of animal semen, milk, and beer. Its products include NucleoCounter NC-3000, an advanced image cytometer;

Frequently asked questions

What is ChemoMetec A/S's market cap?

ChemoMetec A/S's market capitalization is DKK 6.45B.

What is ChemoMetec A/S's P/E ratio?

ChemoMetec A/S's price-to-earnings (P/E) ratio is 36.4.

Does ChemoMetec A/S pay a dividend?

ChemoMetec A/S has a dividend yield of 1.9%.

What does ChemoMetec A/S do?

ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.